Introduction: Laparoscopic hepatectomy is considered an acceptable treat-
Introduction
The role of laparoscopic liver resection (LLR) has been established for liver cancer management. After two consensus meetings regarding LLR, the recommendation for LLR became stronger (1, 2) . However, the technique requires great technical skill, which is one of the downsides of LLR.
Liver resection is a difficult operation, and using the laparoscopic approach to this surgery is particularly challenging. The surgeon's movements are restricted in the laparoscopic operation because of location of the port sites. The use of laparoscopic instruments offers surgeons no tactile sensation. The immunofluorescence technique has been used in open surgery (3) . The laparoscopic application of this technique may compensate for the limitations of the laparoscopic procedure otherwise.
There are limited data regarding the use of the immunofluorescence technique in LLR in patients with hepatocellular carcinoma (HCC) and cirrhosis. The objective of this study was to investigate the effect of the indocyanine green (ICG) immunofluorescence technique on LLR for patients with HCC and cirrhosis.
Patients and Methods
From January 2015 to June 2016, 20 patients underwent LLR at our hospital for HCC and cirrhosis. All the patients had pathological proof of HCC and liver cirrhosis. All the procedures were carried out by the first author. Lesions picked up by ICG immunofluorescence were evaluated by the operating surgeon and the assistant. All the data were prospectively recorded and put into a database by a single research assistant. The outcomes of patients who underwent pure laparoscopic hepatectomy with ICG immunofluorescence for primary HCC (the laparoscopic group) were compared with the outcomes of propensity score-matched patients who underwent open hepatectomy for primary HCC (the open group).
The PINPOINT laparoscopic fluorescence imaging system (NOVADAQ, Toronto, Canada) was used in the operations. The ICG retention test is a routine liver function assessment for patients with liver cirrhosis. Patients received an intravenous injection of 0.5-mg/kg ICG 10 days before operation (4). For patients who underwent operation more than 2 weeks after the initial ICG retention test, another intravenous injection of 0.5-mg/ kg ICG was given 24 h before the operation.
During LLR, the patient was usually placed in the French position. The primary surgeon stood between the patient's legs with one assistant on each side. A 30 telescope was inserted after subumbilical cut-down. Pneumoperitoneum was maintained at 12 mmHg. Laparoscopic examination using white light and infrared ICG was performed to identify the targeted lesion and search for additional lesions. The bile duct system was examined by the ICG immunofluorescence technique. An ultrasound examination was performed to confirm the location and size of the tumor and to check for additional lesions.
Usually two or three working ports were used for minor hepatectomies and four or five were used for major hepatectomies. An ultrasonic dissector or Cavitron Ultrasonic Surgical Aspirator ® was used for liver parenchymal transection (5) (6) (7) (8) The primary outcome measurement was survival, and secondary outcome measurements were operation time, blood loss, blood transfusion requirement, complications, and length of hospital stay. Survival analysis was performed based on disease-free survival versus disease recurrence or death. The Kaplan-Meier method was used to compute survival, and the log-rank test was used for survival comparison.
The propensity score analysis model was used to eliminate potential bias of case match selection. Variables with potential influence on the outcomes were assigned propensity scores after logistic regression analysis. Based on the generated propensity scores, the nearest neighbors in each of the two groups were matched one to one, and survival outcomes in the two groups were then compared. Statistical significance was set at P < 0.05. The computer software SPSS/PC+ (SPSS, Chicago, USA) was used for all statistical calculations.
Results
There were 20 patients in the laparoscopic group and 120 patients in the open group. Propensity score matching was performed in terms of age, sex, liver function, tumor size, number of tumors, tumor stage, hepatitis serology, and comorbidities. A comparison of baseline characteristics between the two groups of patients can be viewed in Table 1 .
Among the 20 laparoscopic patients, five (25.0%) underwent major hepatectomy (two right hepatectomies, one left hepatectomy, one extended left hepatectomy, and one right trisectionectomy), nine underwent wedge resection, two underwent monosegmentectomy, and four underwent left lateral sectionectomy.
In the laparoscopic patients, 26 tumors were identified before operation by CT scan. All of these lesions were detected by the ICG fluorescence technique during laparoscopic examination or parenchymal transection ( Figure 1 ).
Three additional nodules were determined to be suspicious by the operating surgeon and assessor and were then excised. One was found to be a high-grade dysplastic nodule, and the other two were found to be regeneration nodules.
One biliary leakage was identified at the end of laparoscopic right hepatectomy under fluorescence mode. An additional metal clip was applied to the leakage site, and the patient did not have any complication after the surgery (Figure 2) .
The median blood loss was 125 mL in the laparoscopic group and 450 mL in the open group (P < 0.001). The median operation time was 200.0 min in the laparoscopic group and 250.5 min in the open group (P = 0.003). The median hospital stay was shorter in the laparoscopic group (5 vs 6 days, P < 0.001). During the final pathological examination, no patient in the laparoscopic group was found to have a positive resection margin (Table 2) .
There was no reported complication in the laparoscopic group, whereas 18 patients (15.0%) in the open group developed complications. Details of the complications are listed in Table 3 .
The 1-and 2-year overall survival rates were 95.0% and 95.0%, respectively, in the laparoscopic group and 97.5% and 94.0%, respectively, in the open group (P = 0.875) (Figure 3a) . The 1-and 2-year disease-free survival rates were 90.0% and 90.0%, respectively, in the laparoscopic group and 84.9% and 76.1%, respectively, in the open group (P = 0.267) (Figure 3b ).
Discussion
Laparoscopic resection is an advanced technique that has been proven safe in expert hands (5) (6) (7) (8) (9) (10) (11) (12) . The shortterm advantages of this approach include less blood loss, shorter hospital stay, and possibly fewer complications. These favorable outcomes have been demonstrated in patients with liver cirrhosis in previous studies (5) (6) (7) (8) (9) .
In laparoscopic surgery, surgeons can use neither their hands to palpate the liver to search for additional tumors nor their fingers to mark the resection margin. The fluorescent imaging technique could help overcome these limitations.
The application of fluorescence imaging with ICG has been rapidly expanding in the field of minimally invasive surgery, including gastrointestinal surgery and hepatobiliary surgery. The PINPOINT laparoscopic fluorescence imaging system uses a metal-oxide semiconductor camera head and a near-infrared laser diode for ICG excitation at a wavelength of 805 nm. The imaging system provides color images under white-light illumination, monochromatic fluorescence images under near- infrared light illumination, and fusion images superimposed after computer calculation. This type of augmented reality technique makes real-time assessment of suspected lesions possible. In hepatobiliary surgery, ICG fusion images are useful for hepatic lesion identification, margin assessment, hepatic perfusion, and visualization of hepatic segments and the biliary system. Once injected intravenously, ICG is metabolized in liver cells at a normal rate; more than 86% of ICG should be cleared within 15 minutes in a patient with normal liver function (4, 13) . Hepatic lesions (e.g. HCC, dysplastic nodules, liver metastases, and adenoma) are depleted of liver cells with normal function, and therefore, the cells retain ICG for a much longer time. Surgeons can then identify all of the suspected lesions, and at the same time, the resection can be planned and performed with an adequate margin under direct visualization (13, 14) . Previously, the false-positive rate of the ICG technique was reported to be as high as 40% (3, 15) . Therefore, when a suspicious lesion is not diagnosed preoperatively and found by ICG fluorescence imaging, additional resection should be considered only if the lesion is superficially located and appears suspicious on intraoperative ultrasound examination. In our current study, two-thirds of the additional lesions were found to be benign. Another advantage of ICG fluorescence in LLR is that it enables better assessment of the bile duct in relation to the surrounding structures. This provides additional information in case of cholangiography. As shown in Figure 4 , in a case of right hepatectomy, there was a low bifurcation of the left bile duct, which was considered a branch of the right hepatic artery. Before the division of this structure, the anomaly was correctly identified with ICG fluorescence, and an inadvertent division of a vital structure was avoided. For bile duct identification, 0.025-mg ICG should be injected intravenously 20-30 min in advance. The biliary excretion of ICG starts within minutes after injection and peaks at 2 h. Once the intensity of the bile duct image has diminished, reinjection of ICG can be considered (16) . Compared with a conventional radiographic cholangiogram, a fluorescence image has the additional advantage of a superimposed image, which can influence a surgeon's decision when a biliary system has suspicious anatomy. Furthermore, an ICG fluorescence augmented reality cholangiogram can eliminate the need for cystic duct cannulation and therefore prevent bile leakage.
For patients with limited liver reserve in various stages of liver cirrhosis, anatomical segmentectomy provides a better oncological outcome when compared with nonanatomical segmentectomy. In open surgery, the supplying pedicle can be clamped after a hepatotomy. The clamping should result in a demarcation of the anatomical segment due to ischemia of the region. Alternatively, an injection of blue dye into the supplying portal vein can be used to mark the boundary of the resection. These techniques can also be applied in laparoscopic surgery (17) . In one of our In this study, the complication rate was lower in the laparoscopic group, but the difference was not statistically significant. We understand that to show a 15% difference in complication rate between the laparoscopic group and the open group, there should be around 100 cases in each study group. In our previous study involving 440 patients, the complication rate was likewise lower in the LLR group, but the difference was statistically significant (5) .
The most important outcome of cancer surgery is patient survival. In this study, we demonstrated improved short-term outcomes and non-inferior survival up to 2 years in patients with HCC and cirrhosis who had undergone LLR. Because this study had a retrospective design and was not randomized, it does have some limitations. We tried to overcome selection bias by employing propensity score matching. The propensity score model reduced the differences in the distribution of covariates among individuals allocated to a specific intervention. Theoretically, a randomized controlled trial can provide the most unbiased evidence for clinical science, but it would be difficult to recruit patients given that the hypothesis assumption posits that both treatment arms would provide similar results.
